Skip to main content
Premium Trial:

Request an Annual Quote

Synamatix Licenses Bioinformatics Service to Beatson Institute via MGRC

NEW YORK, Sept. 6 (GenomeWeb News) - Synamatix said today that its Kuala Lumpur-based Malaysian Genomics Resource Center has licensed online bioinformatics services based on Synamatix technology to UK-based Beatson Institute for Cancer Research.

 

All MGRC applications are based on Synamatix's SynaSuite bioinformatics tools and are built on the company's core IP, SynaBase, a structured network database for storing biological data.

 

The MGRC service will be used to support cancer research being led by Keith Vass, head of bioinformatics at the Beatson Institute, the company said.

 

Financial terms of the deal were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.